Vafidemstat (ORY-2001) (Synonyms: ORY-2001) |
カタログ番号GC31101 |
Vafidemstat (ORY-2001) (ORY-2001) は、経口の脳浸透性二重リジン特異的ヒストン脱メチル化酵素 (LSD1)/MAO-B 阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1357362-02-7
Sample solution is provided at 25 µL, 10mM.
Vafidemstat (ORY-2001) is a dual lysine-specific histone demethylase (LSD1)/MAO-B inhibitor.
Vafidemstat (ORY-2001), a dual LSD1/MAO-B inhibitor, is a novel epigenetic agent for the treatment of neurodegenerative diseases. LSD1 is a protein that participates in transcription regulation complexes; its modulation can be used to tweak transcriptional imbalances in neurodegenerative disease and redress neuroinflammation and cognitive deficit[1]. Vafidemstat (ORY-2001) can be used in the treatment of Alzheimer's disease[2].
[1]. ORYZON presents data on the Phase I trial with ORY-2001 at the 13th International Conference on Alzheimer's and Parkinson's diseases [2]. ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2018.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *